| M |
2026-04-27 19:08 |
2026-04-23+ |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$3.56 |
+570.2K |
12.68M |
+5% |
+$2.03M |
| MI |
2026-04-27 19:08 |
2026-04-23+ |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
12.68M |
New |
— |
| M |
2026-04-20 19:24 |
2026-04-16+ |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$3.57 |
+182.9K |
12.11M |
+2% |
+$652.9K |
| MI |
2026-04-20 19:24 |
2026-04-16+ |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
12.11M |
New |
— |
| MI |
2025-04-07 |
2025-04-03+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
12.70M |
New |
— |
| M |
2025-04-07 |
2025-04-03+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$16.12 |
+845.2K |
12.70M |
+7% |
+$13.63M |
| MI |
2025-04-02 |
2025-03-31+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
12.49M |
New |
— |
| M |
2025-04-02 |
2025-03-31+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$17.44 |
+54.0K |
12.49M |
+0.4% |
+$941.3K |
| MI |
2025-02-10 |
2025-02-06 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
6.90M |
New |
— |
| M |
2025-02-10 |
2025-02-06 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$2.05 |
+5.17M |
11.41M |
+83% |
+$10.59M |
|
2024-05-13 |
2024-05-09 |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$42.56 |
+1 |
10.77M |
+0.0% |
+$42.56 |
| I |
2024-05-13 |
2024-05-09 |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
10.77M |
New |
— |
| D |
2024-04-15 |
2024-04-11 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$2.92 |
+2.42M |
4.93M |
+96% |
+$7.07M |
| DI |
2024-04-15 |
2024-04-11 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
4.93M |
New |
— |
| I |
2024-02-08 |
2024-02-06 |
LCTX |
Lineage Cell Therapeutics, Inc. |
BROADWOOD PARTNERS, L.P. |
Dir, 10% |
P - Purchase |
— |
0 |
41.67M |
New |
— |
|
2024-02-08 |
2024-02-06 |
LCTX |
Lineage Cell Therapeutics, Inc. |
BROADWOOD PARTNERS, L.P. |
Dir, 10% |
P - Purchase |
$1.04 |
+6.73M |
41.67M |
+19% |
+$7.00M |
| M |
2024-01-05 |
2024-01-03+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$28.61 |
+226.6K |
10.76M |
+2% |
+$6.48M |
| MI |
2024-01-05 |
2024-01-03+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
10.61M |
New |
— |
| I |
2023-04-05 |
2023-04-03 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
50.18M |
New |
— |
|
2023-04-05 |
2023-04-03 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$0.3 |
+26.83M |
50.18M |
+115% |
+$8.05M |
| M |
2022-12-29 |
2022-12-27+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$47.43 |
+191.1K |
8.74M |
+2% |
+$9.06M |
| MI |
2022-12-29 |
2022-12-27+ |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
8.64M |
New |
— |
| DI |
2022-04-15 |
2022-04-14 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
— |
0 |
23.35M |
New |
— |
| D |
2022-04-15 |
2022-04-14 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
P - Purchase |
$1.33 |
+6.00M |
23.35M |
+35% |
+$7.98M |
| I |
2021-10-01 |
2021-10-01 |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
J - Other |
— |
0 |
8.59M |
New |
— |
|
2021-10-01 |
2021-10-01 |
STAA |
STAAR SURGICAL CO |
BROADWOOD PARTNERS, L.P. |
10% |
J - Other |
$0.00 |
-71.6K |
8.59M |
-0.8% |
$0 |
| D |
2021-09-24 |
2021-09-23 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
X - OptEx |
$3.15 |
+573.5K |
17.35M |
+3% |
+$1.81M |
| DI |
2021-09-24 |
2021-09-23 |
IMDX |
Insight Molecular Diagnostics Inc. |
BROADWOOD PARTNERS, L.P. |
10% |
X - OptEx |
— |
0 |
17.35M |
New |
— |